These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37461938)

  • 1. P018 How to Improve Transition of Pediatric IBD Patients Through Use of EMR.
    Johnson G; Walker C; Miller J; Steiger A; Bittner K; Abell R; Marino D
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S4-S5. PubMed ID: 37461938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists.
    Hait EJ; Barendse RM; Arnold JH; Valim C; Sands BE; Korzenik JR; Fishman LN
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):61-5. PubMed ID: 19172125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, evaluation, and management of obesity in an academic primary care center.
    O'Brien SH; Holubkov R; Reis EC
    Pediatrics; 2004 Aug; 114(2):e154-9. PubMed ID: 15286251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a Mixed-method Approach to Develop a Transition Program for Young Adults With Inflammatory Bowel Disease.
    Maddux MH; Drovetta M; Hasenkamp R; Carpenter E; McCullough J; Goyal A; Bass J
    J Pediatr Gastroenterol Nutr; 2020 Feb; 70(2):195-199. PubMed ID: 31978016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
    Bay M C; Núñez F P; Quera R; Yarur AJ
    Gastroenterol Hepatol; 2023 Feb; 46(2):139-147. PubMed ID: 36243253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Summary Template for the Transfer of Patients with Inflammatory Bowel Disease from Pediatric to Adult Care.
    Benchimol EI; Afif W; Plamondon S; Newhook D; Nicholls SG; Lévesque D
    J Can Assoc Gastroenterol; 2022 Feb; 5(1):3-11. PubMed ID: 35118221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition.
    Nardone OM; Martinelli M; de Sire R; Calabrese G; Caiazzo A; Testa A; Rispo A; Miele E; La Mantia A; D'Alessandro E; Fioretti MT; Limansky L; Ferrante M; Di Luna I; Staiano A; Castiglione F
    Therap Adv Gastroenterol; 2024; 17():17562848241241234. PubMed ID: 38827647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric to adult inflammatory bowel disease transition: the Asian experience.
    Tan B; Ong D
    Intest Res; 2020 Jan; 18(1):11-17. PubMed ID: 32013311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to and requirements for a successful transition in inflammatory bowel disease from pediatric to adult care in Greece.
    Giouleme O; Koutsoumourakis A; Katsoula A; Katsaros M; Soufleris K; Vasilaki K; Xinias I
    Ann Gastroenterol; 2023; 36(5):541-548. PubMed ID: 37664230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Transition from Pediatric to Adult Care in Inflammatory Bowel Disease: What is the Key?
    Kim J; Ye BD
    Pediatr Gastroenterol Hepatol Nutr; 2019 Jan; 22(1):28-40. PubMed ID: 30671371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful transition from pediatric to adult care in inflammatory bowel disease: what is the key?
    Kim J; Ye BD
    Intest Res; 2019 Jan; 17(1):24-35. PubMed ID: 30419636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional survey of Saudi gastroenterologists: Transition strategies for adolescents with inflammatory bowel disease.
    Al-Jahdali E; Mosli M; Saadah O
    Saudi J Gastroenterol; 2017; 23(4):233-237. PubMed ID: 28721977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitional Care for Patients with Inflammatory Bowel Disease: Japanese Experience.
    Kumagai H; Suzuki Y; Shimizu T
    Digestion; 2021; 102(1):18-24. PubMed ID: 33032280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Mobile HealthPROMISE Platform on the Quality of Care and Quality of Life in Patients With Inflammatory Bowel Disease: Study Protocol of a Pragmatic Randomized Controlled Trial.
    Atreja A; Khan S; Rogers JD; Otobo E; Patel NP; Ullman T; Colombel JF; Moore S; Sands BE;
    JMIR Res Protoc; 2015 Feb; 4(1):e23. PubMed ID: 25693610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.